Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Attached please find Footnote 14 on Income Taxes from Coca Cola's 2016 Annual Report. Note the statutory US tax rate is 35% What is Coke's

image text in transcribedimage text in transcribedimage text in transcribed

Attached please find Footnote 14 on Income Taxes from Coca Cola's 2016 Annual Report. Note the statutory US tax rate is 35%

  1. What is Coke's 2016 (effective tax rate) ETR? Include all U.S., state and local, and international taxes.
  2. How much tax did Coke save, or extra tax spent, ad which one, due to its foreign operations?
  3. By how much has tax deductible depreciation expense exceeded, or been less than ( and which one book depreciation expense cumulatively thru year end 2016?
  4. Repeat #3 for2016 only
  5. At the beginning of 2017, the U.S. Statutory tax rate fell to 21%. How much gain or loss, and which one, did Coke experience as a result of this change?

image text in transcribedimage text in transcribedimage text in transcribed
Multi-Employer Pension Plans As a result of our acquisition of Old CCE's North America business in 2010, the Company now participates in various multi-employer pension plans in the United States. Multi-employer pension plans are designed to cover employees from multiple employers and are typically established under collective bargaining agreements, These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan. Multi-employer plans are generally governed by a board of trustees composed of management and labor representatives and are funded through employer contributions. The Company's expense for U.S. multi-employer pension plans totaled$41 million, $40 million and $38 million in 2016, 2015 and 2014, respectively. The plans we currently participate in have contractual arrangements that extend into 2021. If, in the future, we choose to withdraw from any of the multi-employer pension plans in which we currently participate, we would need to record the appropriate withdrawal liabilities at that time. NOTE 14: INCOME TAXES Income before income taxes consisted of the following (in millions): Year Ended December 31, 2016 2015 2014 United States : 113 \\ S CH 1,801 1,567 International 8,023 7,804 7,758 Total ::. 8,136 $ 9,605 $ 9,325 I Includes $2,456 million in charges related to refranchising certain bottling territories in North America. Refer to Note 2, Income tax expense consisted of the following for the years ended December 31, 2016, 2015 and 2014 (in millions): United States State and Local Intemaliona Total 2016 :: Current 1,147 113 S 1,182 S 2,442 Deferred (838) (91) (856) 2015 :69:: 2,166 Deferred 120 45 (92) 73 2014 Current 867 81 1,293 2,24 Deferred (97) (21 78: (40 ) Includes the benefit from charges related to refranchising certain bottling territories in North America. Refer to Note 2. We made income tax payments of $1,554 million, $2,357 million and $1,926 million in 2016, 2015 and 2014, respectively. 119A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows: Year Ended December 31, 2016 2015 2014 Statutory U.S. federal tax rate : 35.0 % 350% :35.0% State and local income taxes - net of federal benefit 1.2 1.2 1.0 Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate (17.5) (12.7) (11.5) M.15 Equity income or loss 3.0) (1.7) 10 (2.2) Other operating charges 1.2 2.9 16,47 Other - 2.4 78 0.3 13 (1.6) Effective tax rate. 23.3% 23.6 % Includes a pretax charge of $72 million (or a 0.3 percent impact on our effective tax rate) related to charges resulting from remeasuring our net monetary assets denominated in Egyptian pounds. Refer to Note 17. 2 Includes a tax benefit of $68 million (or a 0.8 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions as well as tax settlements with various international jurisdictions. 3 Includes a tax charge of $189 million related to a pretax gain of $1,323 million (or a 3.4 percent impact on our effective tax rate) related to the deconsolidation of our German bottling operations and a net pretax gain of $18 million related to the disposal of our investment in Keurig, partially offset by a pretax loss of $21 million related to the deconsolidation of our South African bottling operations. This charge also includes the tax impact resulting from the accrual of tax on temporary differences related to the investment in foreign subsidiaries that are now expected to reverse in the foreseeable future. Refer to Note 2 Includes an $1 1 million tax benefit on a pretax charge of $61 million (or a U. 1 percent impact on our effective tax rate) related to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 17 Includes a tax benefit of $74 million on pretax charges of $309 million (or a 0.4 percent impact on our effective tax rate) which primarily included $200 million in cash contributions to The Coca-Cola Foundation, a $76 million charge due to the write-down we recorded related to receivables from our bottling partner in Venezuela and a $32 million charge due to tax litigation expense. Refer to Note 17. " Includes a tax benefit of $338 million on pretax charges of $1,201 million (or a 1.0 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18. Includes a tax expense of $157 million (or a 1.9 percent impact on our effective tax rate) primarily related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties in certain domestic jurisdictions. Includes a tax expense of $753 million primarily on pretax charges of $2,456 million (or a 1.4 percent impact on our effective tax rate) related to the refranchising of certain bottling territories in North America. Refer to Note 2. Includes a pretax charge of $27 million (or a 0.1 percent impact on our effective tax rate) due to the remeasurement of the net monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SIMADI exchange rate. Refer to Note 1 and Note 17. 10 Includes a tax benefit of $5 million on a pretax charge of $87 million (or a 0.3 percent impact on our effective tax rate) related to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 17 Includes a tax benefit of $45 million on a pretax charge of $225 million (or a 0.3 percent impact on our effective tax rate) primarily due to an impairment of a Venezuelan trademark, a write-down of receivables from our bottling partner in Venezuela, a cash contribution to The Coca-Cola Foundation and charges associated with ongoing tax litigation. Refer to Note 1 and Note 17. 12 Includes a tax benefit of $259 million on pretax charges of $983 million (or a 0.9 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestinent program as well as other restructuring initiatives. Refer to Note 18. 13 Includes tax expense of $150 million on pretax income of $77 million (or a 1.3 percent impact on our effective tax rate) primarily due to the gain related to the Monster Transaction, offset by charges related to the refranchising of certain bottling territories in North America and charges associated with the early extinguishment of long-term debt. Refer to Note 2 and Note 17. 14 Includes tax expense of $6 million on a pretax net charge of $372 million (or a 1.5 percent impact on our effective tax rate) due to the remeasurement of the act monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SICAD 2 exchange rate. Refer to Note 1. 15 Includes tax expense of $18 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions. 16 Includes tax expense of $55 million on a pretax charge of $352 million (or a 1.9 percent impact on our effective tax rate) primarily due to an impairment of a Venezuelan trademark, a write-down on ecervables from our bottling partner in Venezuela, a charge associated with certain of the Company's fixed assets, and as a result of the restructuring and transition of the Company's Russian juice operations to an existing joint venture with an anconsolidated bottling partner. Refer to Note I and Note 17. 17 Includes a tax benefit of $191 million on pretax charges of $809 million (or a 1.0 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.As of December 31, 2016, indefinitely reinvested earnings of the Company's foreign subsidiaries amounted to $35.5 billion. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal and state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consist of the following (in millions): December 31, 2016 2015 Deferred tax assets: Property, plant and equipment 'S 144 192 .:Trademarks and other intangible assets : 68 Equity method investments (including foreign currency translation adjustment) 684 694 :Derivative financial instruments" 161 Other liabilities 1,141 1,056 : Benefit plans . 1,599 1,541 Net operating capital loss carryforwards 461 413 Other 135 175 Gross deferred tax assets 1,471 4,300 Valuation allowances (530) (477) Total deferred tax assets ? SS 3,941 $ 3,823 Deferred tax liabilities: Property, plant and equipment (1,176) $ (1,887) : Trademarks and other intangible assets (2,694 ) (3,422) Equity method investments (including foreign currency translation adjustment) (1,718) (1,441) :Derivative financial instruments (1,121 ) (687) Other liabilities (149) (216) (367) Other 635) (726) Total deferred tax liabilities (7,980 (8,746) Net deferred tax liabilities $ (4,039) (4,923) Current deferred tax assets of $80 million and $151 million were included in the line item prepaid expenses and other assets in our consolidated balance sheets as of December 31, 2016 and 2015, respectively. Noncurrent deferred tax assets of $326 million and $360 million were included in the line item other assets in our consolidated balance sheets as of December 31, 2016 and 2015, respectively. Current deferred tax liabilities of $692 million and $743 million were included in the line item accounts payable and accrued expenses in our consolidated balance sheets as of December 31, 2016 and 2015, respectively. As of December 31, 2016 and 2015, we had net deferred tax assets of $83 million and $62 million, respectively, located in countries outside the United States. As of December 31, 2016, we had $4,320 million of loss carryforwards available to reduce future taxable income. Loss carryforwards of $331 million must be utilized within the next five years, and the remainder can be utilized over a period greater than five years

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access with AI-Powered Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Fundamentals of biochemistry Life at the Molecular Level

Authors: Donald Voet, Judith G. Voet, Charlotte W. Pratt

4th edition

470547847, 978-0470547847

Students also viewed these Accounting questions